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RESUMEN
Se prepara pirazolo[3,4-d]pirimidin-2,4-tiona 4 y [1,3]tia-
zina 5 por reacción de disulfuro de carbono con el ami-
nocianopirazol 3 dependiendo del medio de reacción. La
interacción de 5 y/o 7 con hidrato de hidrazina rinde los
derivados de aminoiminopirazolepirimidina de tipo 6 y
8. El compuesto 6 experimenta diversas reacciones de
ciclación para rendir los derivados de 1,3,4-tiadiazol 9a,b,
mientras que el compuesto 8 rinde los derivados de 1,2,4-
triazol 13a,b. También se obtienen derivados de hexa-
azaciclohepta[e]indeno. Además, se obtienen derivados
de pirazolilpirazolopirimidina al calentar 16 con deriva-
dos de cetenas.
Palabras clave: [1,3]tiazina. 1,3,4-tiadiazol. Pirazolilpira-
zolopirimidina.
SUMMARY
Pyrazolo[3,4-d]pyrimidine-2,4-thione 4 and [1,3]thiazine
5 was formed by the reaction of carbon disulfide with the
aminocyanopyrazole 3 depending on the reaction medi-
um. Interaction of (5 and /or 7) with hydrazine hydrate
yielded the aminoiminopyrazolopyrimidine derivatives of
type 6 and 8. Compound 6 underwent many cyclization
reactions to afford 1,3,4-thiadiazole derivatives 9a,b,
while compound 8 aforded 1,2,4-triazole derivatives
13a,b. Also hexaazacyclohepta[e]indene derivatives were
obtained. Also pyrazolylpyrazolpyrimidine derivatives
were obtained upon heating of 16 with ketene deriva-
tives.
Key words: [1,3]thiazine. 1,3,4-thiadiazole. Pyrazolyl-
pyrazolpyrimidine.
RESUM
Es prepara pirazol[3,4-d]pirimidin-2,4-tiona 4 i [1,3]tiazi-
na 5 per reacció de disulfur de carboni amb l’aminocia-
nopirazole 3 depenent del medi de reacció. La interac-
ció de 5 i/o 7 amb hidrat d’hidrazina rendeix els derivats
d’aminoiminopirazolepirimidina de tipus 6 i 8. El com-
post 6 experimenta diverses reaccions de ciclització per
rendir els derivats d’1,3,4-tiadiazole 9a,b, mentre que el
compost 8 rendeix els derivats d’1,2,4-triazole 13a,b.
També s’obtenen derivats d’hexaazacicloheptan[e]indè.
A més, s’obtenen derivats de pirazolilpirazolepirimidina
en escalfar 16 amb derivats de cetens.
Mots clau: [1,3]tiazina. 1,3,4-tiadiazole. Pirazolilpirazole-
pirimidina.
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INTRODUCTION
Certain pyrazolol[3,4-d ]pyrimidines exhibit phosphodi-
esterase inhibitory action(1) and others have shown herbi-
cidal activity(2). 
It well known that uric acid is a breakdown product of purine
in foods, so that allopurrinol is used to lower blood uric
acid levels, prevent uric acid kidney stones and to prevent
attacks arthritis recurrent gouty(3). These findings encour-
aged us to synthesis some new pyrazolo[3,4-d]pyrimidine
ring systems as analogy to allopurrinol.
DISCUSSION
Our goal is to develop new general and convenient pro-
cedures for the preparation of fused pyrazolopyrimidine
derivatives 6,7(4, 5). Thus, the interaction of ethoxymethyl-
ene malononitrile 1 with p-nitrophenylhydrazine 2 gave 5-
amino-4-cyano-1-(p-nitrophenyl) pyrazole 3 according to
Afred Kreutzberger et al(6).
The obtained product from the reaction of 3 with carbon
disulphide was varied according to the reaction medium.
In aqueous potassium hydroxide, 1-(4-nitrophenyl)-1H-
pyrazolo[3,4-d]pyrimidine-4,6(5H,7H)-dithione (4) was form-
ed. Meanwhile, in pyridine, 4-imino-(4-nitro -phenyl)pyra-
zolo[3,4-d][1,3]thiazine-2(1H)-thioxy (5) was formed.
5 Underwent Dimroth rearrangement in which diothioxo
derivative 4 was obtained(7, 8) (Scheme 1).
The structure of the obtained products 4,5 were confirmed
from their agreeable elemental and spectral data. In addi-
tion to the chemical confirmation reactions. 
Compound 5 underwent neucleophlic substitution reac-
tion with hydrazine hydrate affording 6. On the other hand,
when 3 treated with (1:1) triethylorthoformate and acetic
anhydride gave 7, which under went cyclization reaction
with hydrazine hydrate affording 8. 
Reaction of 6 with either triethylorthoformate or acetate
afforded 1-(4-nitro phenyl) (diethoxymethyleneimino)1,3,4-
thiadiazolo derivatives 9a,b in spite of 10 in accordance
to their spectral and elemental analyses data (Scheme 2)(9).
1H-NMR of 9a, revealed signals at 4.20 (m, 4H, 2CH2), 4.40
(s, 1H, CH, methylene), 1.4 (m, 6H, 2CH3). 4-Aceto-
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thiadiazolopyrimidine 11 was also obtained upon heating
of 6 with hydrazine hydrate (Scheme 2). 1H-NMR of 11
showed a characteristic signal at 4.34 (s, 3H, COCH3).
Compound 8 underwent cyclocondensation reaction upon
treatment with carbon donor reagent like triethyl orthofor-
mate or triethyl orthoacetate to furnish pyrazolo[4,3-e][1,2,4]
triazolo[3,2-c]pyrimidine derivatives 12a,b.
The structure of the formed compound was confirmed
chemically when 7 reacted with acetohydrazide or furyl-
carbohydrazide to afford 13b,c. In addition, the agreement
of the proposed structure with the spectral and analytical
data obtained (Scheme 3).
Therefore, 1H-NMR 12a-d revealed characteristic signals
for pyrazolo[4,3-e] [1,2,4]- triazolo[3,2-c]pyrimidine deriv-
atives.
Also, in the finding that phosphorous oxychloride consid-
ered as a good cyclizing agent(10). Therefore, we prepare
5,6-diaryl-1-(4-nitrophenyl)-7(1H)-pyrazolo-[3,4:2/:3/][1,3,4]tri-
azino[2,3-c]pyrimidine 13 a, b when 8 treated with ben-
zoin or acetoin, respectively (Scheme 3).
Since the discovery of benzodiazepines(bz) in 1960, exten-
sive research efforts in the field led to development of a
variety of modified derivatives(11, 12).
This results prompted us to design and synthesize some
of related formula 14,15. 3-(4-Nitrophenyl)-3H-2,3,4,5a,6,10-
hexaaza-cyclohepta[e]indene derivatives were obtained  via
the reaction of 8 with either malononitrile or ethylcyano
acetate in acidic medium. The structure of the formed com-
pounds were built on their spectral date (Scheme 4). IR (KBr)
for 14,15 showed characteristic peaks at 4435-4342 v (NH2),
4576(OH); 1H-NMR 14,15 showed signals at 8.29, 8.21
(CH, hept-H).
On the other hand when 8 treated with malononitrile or eth-
ylcyano acetate, 1-(4-nitrophenyl)-4-pyrazol-1-yl-1H-pyra-
zolo[3,4-d] pyrimidine derivatives 17,18 were obtained.
Also pyrazlylpyrazolpyrimidine 20,21 derivatives were
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obtained upon heating of 8 with ketene derivatives in basic
medium(13-16). Therefore we can concluded that the reaction
medium affected on the products obtained.
Reaction of ketene derivatives 20, 21 with hydrazino deriv-
atives 12 gave 22, 23 respectively. 
EXPERIMENTAL
Melting points were determined in open capillary tubes and
are uncorrected. The purities of the compounds were
checked on silica-gel-coated Al plates (Merck). Micro-
analyses were performed by micro analytical Unit, NRC.
All compounds gave satisfactory values for C, H, Cl, N and
S within range of ± 0.04. IR spectra (KBr) were recorded
on Perkin Elmer 580 spectrophotometer. 1H-NMR were car-
ried on JNM,FT-NMR-EX270, run 1H-NMR 270 MHz, in
DMSO-d6 using TMS as internal standard and chemical
shifts are expressed in δ ppm. Mass spectra were record-
ed on Varian Mat 112 spectrometer.
1-(4-nitrophenyl)-1H-pyrazolo[3,4-d ]pyrimidine-
4,6(5H,7H)-dithione (4)
To a solution of 3 (2.41 g,10 mmloe) in 10% alcoholic potas-
sium hydroxide(10 ml), carbon disulphide (10 ml) was added
and the reaction mixture was allowed to heat for 6 hrs. After
cooling, the reaction mixture was poured onto ice-water,
and the formed solid was collected by filtration and was
washed several times with water, was dried and was crys-
tallized from dioxane affording pale yellow crystals and
was identified as 4.
Crystallization from dixane m.p. 270-2ºC yield %75; Mol. for.
C11H7N5O2S2, mol. wt. 305.33, IR (KBr) v cm
–1 3320 (NH); 1H-
NMR(DMS-d6) δ ppm: 8.40, 7.88 (2d, j = 8Hz, 4H, Ar-H), 7.83
(s, 1H, pyrazole), 7.80, 7.09 (2bs, 2H, exchangeable with
D2O, 2NH). MS (m/z%): 305 (34%), 95 (100%).
4-Imino-1N(4-nitrophenyl)pyrazolo[3,4-d][1,3]thiazine-6-
(1H, 4H, 7H )-thione (5).
To a solution of 3 (2.41 g, 10 mmloe) in dry pyridine (20 ml),
carbon disulphide (10 ml) was added and the reaction mix-
ture was allowed to heat for 6 hrs. After cooling, the reac-
tion mixture was poured onto ice-water, and the formed
solid was collected by filtration and washed several times
with water, dried and crystallized from ethanol affording
buff crystals and was identified as 5. 
Crystallization from ethanol, m.p. 223-5ºC yield% 80.
Mol. for. C11H7N5O2S2, mol. wt. 305.33, IR (KBr) v cm
–1 3320
(NH); 1H-NMR (DMS-d6) δ ppm: 8.39, 7.90 (2d, j = 8Hz, 4H,
Ar-H), 7.81 (s, 1H, pyrazole), 7.72, 7.09 (2s, 2H, exchange-
able with D2O, 2NH). MS (m/z%): 305 (34%), 95 (100%).
5-Amino-4-imino-4,5-dihydro-1-(4-nitrophenyl)-1H-pyra-
zolo[3,4-d]pyrimidine-6-(7H)-thione (6).
A mixture of 5 (3.05 g,10 mmole), hydrazine hydrate (0.75 g,
15 mmole) in acetic acid (25 ml) was stirred at 0ºC for 4 hrs.
The reaction mixture was poured onto water and the
deposited solid was filtered off, washed with water sever-
al times to afford 6. 
Crystallization from ethanol, m.p. 210-2ºC, yield% 86,  mol.
for. C11H9N7O2S, mol. wt. 303.31; 
1H-NMR (DMSO-d6) δ ppm
8.36-7.88 (2d, j = 7hz, 4H, Ar-H), 7.80 (s, 1H, pyrazole), 7.92,
7.19 (s, 2H, exchangeable with D2O, 2NH), 3.36 (s, 2H,
exchangeable with D2O, NH2); MS (m/z%): 303 (18%), 65
(100%).
Ethyl-N-{5-cyano-2-(4-nitrophenyl)1,2-pyrazolo}metha-
nimidate (7).
A mixture of 3 (1 g, 3 mmole), triethyl orthoformate and
acetic anhydride (1:1) was heated under reflux for 8 hrs.
The reaction mixture was cooled then the solid was formed
was collected by filtration  and was crystallized from
methanol to afford 7. Crystallization from ethanol: m.p. 98-
100ºC yield% 56 Mol. for. C13H11N5O3, mol. wt. 285.26;  IR
(KBr) v cm–1 2220 (CN), 1670 (CO, ester); 1H-NMR (DMSO-
d6) δ ppm 8.56, 7.95 (2d, j = 9Hz, 4H, Ar-H), 8.01 (s, 1H,
N = CH), 7.88 (s, !H, pyrazole), 4.45 (q, 2H, CH2), 1.35 (m,
3H, CH3); MS (m/z%): 286 (30%), 57(100%).
5-Amino-4(5H)-imino-1-(4-nitrophenyl)-1H-pyrazolol[3,4-
d ]pyrimidine (8).
A mixture of 7 (2.86 g, 10 mmole), hydrazine hydrate (0.75 g,
15 mmole) in ethanol (25 ml) was stirred at 0ºC for 4 hrs.
The reaction mixture was poured onto water and the
deposited solid was filtered off, was washed with water
several times to afford 8. 
Crystallization from ethanol; m.p. 272-4ºC with 78% yield;
mol. for. C11H9N7O2; mol. wt. 271.24 IR (KBr) v cm
–1 3460-
3380 (NH2), 3220 (NH); 
1H-NMR (DMSO-d6) δ ppm 8.40 (s, 1H,
pyrimidine), 8.35, 7.88 (2d, j = 9 Hz, 4H, Ar-H), 7.86 (s, 1H,
pyrazole), 6.65 (s, H, exchangeable with D2O, NH) 4.20 (s, 2H,
exchangeable with D2O, NH2); MS (m/z%): 272 (20%), 57
(100%).
General procedure for the preparation of (9a,b; 11; 12a,b
(method a)).
A mixture of 6 (1 g, 3 mmole) or 8 (0.81, 3 mmole), and tri-
ethyl orthoformate, acetate (3 ml) and acetic anhydride
respectively, was heated under reflux for 10 hrs. The reac-
tion mixture was cooled then the solid was formed was col-
lected by filtration and was crystallized from proper solvent.
4-α-Methyl,α,α/-diethoxy)methylene-1-(4-nitrophenyl)pyra-
zolo[3,4-d][1,3,4] thiadizolo[3,2-c]pyrimidine(9a).
Crystllization from EtOH; m.p. 240-2ºC; yield% 56; mol. for.
C17H17N7O4S;  Mol. wt. 415.44; 
1H-NMR (DMSO-d6) δ ppm
8.50 (s, 1H, CH, methylene), 8.45-7.82 (2d, j = 9 Hz, 4H, Ar-
H), 8.33, 8.01 (2s,!H, pyrazole and thiadizole-H), 4.20 (m,
4H, 2CH2), 1.40 (t, j = 11 Hz, 6H, 2CH3); MS (m/z%): 415
(55%).56 (100%).
2-Methyl-5-(α-methyl,α,α/-diethoxy)methyl-8-(4-nitro-
phenyl)pyrazolo[3,4-d][1,3, 4]thiadizolo[3,2-c]pyrimidine
(9b).
Crystallization from dioxane; m.p. 220-2ºC; yield% 47; mol.
for. C19H21N7O4S; mol. wt. 443.50; IR (KBr) v cm
–1 2220 (CN),
1670 (CO, ester); 1H-NMR (DMSO-d6) δ ppm 8.40, 7.80 (2d,
j = 7 Hz, 4H, Ar-H), 7.81 (s, 1H, pyrazole), 4.22 (m, 4H, 2CH2),
1.39 (t, j= 13 Hz, 6H, 2CH3), 2.01, 1.62 (2s, 6H, CH3); MS
(m/z%): 443 (36%).56 (100%).
4-Aceto-2-methyl-8-(4-nitrophenyl)pyrazolo[3,4-
d][1,3,4]thiadizolo[3,2-c]-pyrimidine (11).
Crystalization from EtOH; m.p. 235-7ºC yield% 47 mol. for.
C15H11N7O3; mol. wt. 369.38 S; 
1H-NMR (DMSO-d6) δ ppm.
8.41, 7.76 (2d, j = 11 Hz, 4H, Ar-H), 8.03 (1s, 1H, pyrazole),
4.34 (s, 3H, COCH3), 1.35 (s, 3H, CH3), MS (m/z%) 369 (38%),
256 (100%).
Pyrazol[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine derivatives
(12a-d).
(12a).
Crystallization from EtOH; m.p. 287-9; yield% 80; mol. for.
C12H7N7O2, mol. wt. 281.24. 
1H-NMR (DMSO-d6) δ ppm 9.72
(s, 1H, triazole), 8.62 (s, 1H, pyrimidine), 8.588.36 (2d, j =
8 Hz, 4H, ArH), 7.88 (s, 1H, pyrazole);  MS (m/z%): 281 (30%),
57 (100%).
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Method B
To a solution of 8 (2.7 g, 10 mmole) in ethanol, acetohy-
drazide or furylcarbohydrazide (5 ml) was added. The solu-
tion was allowed to heat under reflux under reflux for 5 hrs.
The reaction mixture was cooled then the solid was formed
was collected by filtration  and was crystallized from ethanol
to afford 12b; m.p. 295-7; yield% 74; mol. for C13H9N7O2;
mol. wt. 292.26 1H-NMR (DMSO-d6) δ ppm 7.62 (s, 1H, pyrim-
idine), 7.98-7.56 (m, 4H, Ar-H), 7.72 (s, 1H, pyrazole), 1.94
(s, 3H, CH3); MS (m/z%): 295 (15%), 95 (100%).
(12c):
Crystallization from EtOH; m.p. 231-3ºC; yield% 46; mol.
for. C16H9N7O3, mol. wt. 348.31. 
1H-NMR (DMSO-d6) δ ppm
8.62 (s, 1H, pyrimidine), 8.62-7.42 (2d, j = 8 Hz, 4H, Ar-H),
7.80, 7.10 (4H, 2d, j = 2, furyl-H); MS (m/z%): 348 (30%), 95
(100%).
General procedure for the preparation of (12d; 13a,b).
An equimolecular amounts of 8 and cyanoacetc acid, ben-
zoin and acetion, respectively in phosphorous oxychloride
(5 ml) was heated under reflux for 3 hrs. The reaction mix-
ture was poured onto water and the deposited solid was
filtered off, was washed with water several times, the sol-
id was crystallized from dioxane to give 12d, m.p. 293-
5ºC; yield % 44; mol. for. C13H8N8O3; mol. wt. 324.25 IR (KBr)
v cm–1 3334 (NH2, amide), 1568 (COamide);  
1H-NMR (DMSO-
d6) δ ppm 8.25 (s, 1H, pyrimidine), 8.53, 8.45 (2d, j = 7 Hz,
4H, Ar-H), 8.41 (bs, 2H, exchangeable with D2O, NH2 amide),
7.82 (s, 1H, pyrazole); MS (m/z%): 324 (18%), 57 (100%).
5 , 6 - D i a r y l - 1 N ( 4 / - n i t r o p h e n y l ) 7 ( 1 H ) p y r a z o -
lo[3,4:2/:3/][1,3,4]triazino-[2,3-c] pyrimidine (13a,b).
(13a)
Crystalization from  dioxane;  m.p. 303-5ºC; yield% 44; mol.
for. C25H17N7O2, mol. wt. 447.45; 
1H-NMR (DMSO-d6) δ ppm,
8.25 (s,1H, pyrimidine), 8.53-7.92 (m, 14H, Ar-H), 7.82 (s, 1H,
pyrazole), 3.21 (s, b, 1H, exchangeable with D2O, NH), MS
(m/z%): 448 (23%), 65 (100%).
(13b):
Crystalization from dioxane m.p. 290-2ºC, yield% 44 mol.
for. C27H21N7O4; mol. wt. 507.52; 
1H-NMR (DMSO-d6) δ ppm,
8.55 (s, 1H, pyrimidine), 8.41-7.92 (m, 12H, Ar-H), 7.90 (s, 1H,
pyrazole), 3.82 (s, 6OCH3), 3.01 (s, b, 1H, exchangeable with
D2O, NH); MS (m/z%): 508 (42%), 95 (100%).
General procedure for the preparation of (14,15)
3-(4-Nitrophenyl)-3H-2,3,4,5a,6,10-hexaaza-cyclohep-
ta[e]indene derivatives (14,15).
An equimolecular amounts of 8 and malononitril, ethyl-
cyanoacetate, respectively in 25 ml acetic acid was heat-
ed for 10 hrs. the reaction mixture was cooled and was
poured onto ice-water. The solid was formed was collect-
ed by filtration, was dried and was crystallized from prop-
er solvent.
(14):
Crystalization; EtOH; m.p. 299-301ºC; yield% 44; mol. for.
C14H11N9O2; mol. wt 337.30; IR (KBr) v cm
–1 3452-3334 (NH2);
1H-NMR (DMSO-d6) δ ppm, 8.51 (s, 1H, pyrimidine), 8.48,
7.90 (2d, j = 9 Hz, 4H, Ar-H), 8.29 (s, 1H, hept-H), 7.68 (s, 1H,
pyrazol) 4.01, 2.78 (2bs, 4H, exchangeable with D2O, 2NH2);
MS (m/z%): 337 (30%), 256 (100%).
(15):
Crystallization; EtOH; m.p.242-4ºC, yield% 51 mol. for.
C14H10N8O3; mol. wt. 338.28; IR (KBr) v cm
–1 3350 (OH); 1H-
NMR (DMSO-d6) δ ppm 8.58, 8.27 (2d, j = 9 Hz, 4H, Ar-H),
8.41 (s, 1H, pyrimidine), 7.62 (s, 1H, pyrazol), 8.21 (s, 1H,
hept-H), 3.01 (s, 1H, exchangeable with D2O, OH); MS
(m/z%): 338 (52%), 256 (100%).
General procedure for the preparation of (17-20):
1-(4-Nitrophenyl)-4-pyrazol-1-yl-4,5-dihydro-1H-pyrazo-
lo[3,4-d]pyrimidine derivatives(17-20).
An equimolar amounts of 8 and malononitril, ethylcyano-
acetate, Keten, respectively and 2-4 drops of piperdine in
25 ml dioxane was heated for 8 hrs. the reaction mixture
was cooled and was poured onto ice-water. The solid was
formed was collected by filtration, was dried and was crys-
tallized from proper solvent.
(17):
Crstallization from dioxane; m.p. 254-6; yield% 62; mol. for.
C14H11N9O2; mol. wt. 337.33; IR (KBr) v cm
–1 3450-3390 (NH2);
1H-NMR (DMSO-d6) δ ppm 8.52 (s, 1H, pyrimidine), 8.27,
7.69 (2d, j = 9 Hz, 4H, Ar-H), 7.62, 7.32 (2s, 2H, pyrazol),
5.52, 3.01 (2s, 4H, exchangeable with D2O, 2NH2); MS
(m/z%): 337 (52%), 256 (100%).
(18): 
Crstallization from dioxane; m.p. 282-4; yield % 62; mol.
for. C14H10N8O3; mol. wt. 338.28; IR (KBr) v cm
–1 3450-3390
(NH2) ,1650 (CO); 
1H-NMR (DMSO-d6) δ ppm 8.41 (s, 1H,
pyrimidine), 8.37, 7.69 (2d, j = 9 Hz, 4H, Ar-H), 7.99 (bs, 1H,
exchangeable with D2O,NH), 7.72, 7.32 (2s, 2H, pyrazol),
3.01 (bs, 2H, exchangeable with D2O, NH2); MS (m/z%): 338
(40%), 256 (100%).
(19): 
Crstallization from methanol m.p. 295-7; yield % 75 mol.
for. C17H14N8O4S; mol. wt. 424.46; IR (KBr) v cm
–1 2220 (CN);
1H-NMR (DMSO-d6) δ ppm 8.51 (s, 1H, pyrimidine), 8.32-
7.61 (2d, j = 9 Hz, 4H, Ar-H), 7.32 (s, H, pyrazol), 4.01 (s, 3H,
SCH3); MS (m/z%): 424 (59%), 229 (100%).
(20):
Crstallization from methanol m.p. 316-8; yield % 81mol.
for. C17H14N8O4S; mol. wt. 426.42; IR (KBr) v cm
–1 1680 (CO
ester); 1H-NMR (DMSO-d6) δ ppm 8.55 (s, 1H, pyrimidine),
8.32, 7.64 (2d, j = 9 Hz, 4H, Ar-H), 7.32 (s, 1H, pyrazol), 4.21
(s, 3H, COOCH3), 4.01 (s, 3H, SCH3),  3.20 (bs, 2H, exchange-
able with D2O, NH2); MS (m/z%): 426 (52%), 229 (100%).
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